JUPITER NEUROSCIENCES, INC.
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
JUNS$2.22+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| September 30, 2025 · September 30, 2024 | ||||
|---|---|---|---|---|
| Cash Flows from Operating Activities: | ||||
| Net Loss | $(6,069,866) | $(911,998) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Loss on change in fair value of derivative liability | - | 53,257 | ||
| Amortization of debt discounts | - | 15,013 | ||
| Gain on extinguishment of debt | - | (951,868) | ||
| Gain on forgiveness of accrued compensation | - | (40,000) | ||
| Non- cash amortization of prepaid contracts | 573,424 | - | ||
| Stock-based compensation | 1,955,275 | 827,357 | ||
| Changes in operating assets and liabilities: | ||||
| Prepaid and other current assets | (27,808) | 25,000 | ||
| Operating lease right of use asset | (2,547) | (1,151) | ||
| Increase in other liabilities | 6,695 | - | ||
| Accounts payable and accrued expenses | 81,869 | 117,555 | ||
| Accrued compensation | 433,959 | 541,135 | ||
| Increase in accrued interest | 3,286 | 110,475 | ||
| Net cash flows from operating activities | (3,045,713) | (215,225) | ||
| Cash Flows from Financing Activities: | ||||
| Proceeds from note payable, related parties | - | 137,000 | ||
| Proceeds from sale of common stock | - | 50,000 | ||
| Net cash flows from financing activities | - | 187,000 | ||
| Net Change in Cash | (3,045,713) | (28,225) | ||
| Beginning of period | 3,769,510 | 28,478 | ||
| End of period | $723,797 | $253 | ||
| Supplemental disclosure of cash flow information: | ||||
| Cash paid for interest | $271 | $56,891 | ||
| Cash paid for income taxes | $ | - | $ | - |
| Non-Cash Investing and Financing Activities: | ||||
| Restricted stock and stock options issued for the forgiveness of accrued compensation | $ | - | $60,000 | |
| Notes payable, related party assign to Note payable | $ | - | $266,667 | |
| Receivables from Sale of Common Stock | $ | - | $75,000 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.